Key statistics
On Friday, AbbVie Inc (ABBV:NYQ) closed at 171.73, 24.76% above the 52 week low of 137.65 set on Nov 29, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 168.59 |
---|---|
High | 172.46 |
Low | 166.92 |
Bid | -- |
Offer | -- |
Previous close | 171.73 |
Average volume | 9.17m |
---|---|
Shares outstanding | 1.77bn |
Free float | 1.77bn |
P/E (TTM) | 59.91 |
Market cap | 303.47bn USD |
EPS (TTM) | 2.87 USD |
Annual div (ADY) | 6.56 USD |
---|---|
Annual div yield (ADY) | 3.91% |
Div ex-date | Oct 15 2024 |
Div pay-date | Nov 15 2024 |
Next div ex-date | Jan 15 2025 |
Next div pay-date | Feb 14 2025 |
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
- PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
- Seaport Therapeutics Names Lauren White as Chief Financial Officer
- NImmune Biopharma Announces R&D Collaboration with BioTherapeutics, Inc. to Advance the Next Wave of Inflammation and Immunology Precision Medicines